CLL
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
CLL
Jun 24, 2024, 02:19 |
Insight
Nitin Jain: Pirtobrutinib Venetoclax and Obinutuzumab in First-Line treatment for CLL
Nitin Jain shared on X: . "Delighted…
Jun 12, 2024, 14:46 |
Insight
Elisa ten Hacken: Finally, the seminars in the Hematology Review Series on CLL have been published
Elisa ten Hacken, Assistant Professor at Weill Cornell Medicine, shared a post on X: "Excited…
Jun 11, 2024, 14:59 |
Insight
Timos Papagatsias: EHA24 is expected to be one of the most exciting EHA conferences to-date!
Timos Papagatsias, CEO of LucidQuest shared a post on LinkedIn: “EHA24 is fast approaching and…
Jun 10, 2024, 16:08 |
Blog
It was great to catch up with Mazyar Shadman at ASCO24 - VJHemOnc
VJHemOnc shared a post on X: "It was great to catch up with Mazyar Shadman at…
May 22, 2024, 01:53 |
Insight
Nitin Jain: Looking forward to presenting phase 2 trial of frontline treatment for patients with CLL at EHA 2024
Nitin Jain, Professor of the Department of Leukemia at MD Anderson Cancer Center, shared on…
May 10, 2024, 11:47 |
Blog
Andrew M. Evens: Thank you for the invite to the 1st HemeOnc Pulse LIVE
Andrew M. Evens, Deputy Director for Clinical Services at Rutgers Cancer Institute, recently shared on…
May 2, 2024, 09:25 |
Blog
Rahul Gosain: HemeSeries with Nitin Jain
Rahul Gosain, Director of Regional Infusion Services at Wilmot Cancer Institute, shared a post on LinkedIn: "HemeSeries:…
Apr 29, 2024, 00:16 |
Insight
Kate Cwynarski: Wonderful talk by Philippe Gaulard
Kate Cwynarski, Haematogist-Oncologist in Lymphoma and CLL at University College London Hospital, shared on X/Twitter:…
Mar 19, 2024, 03:44 |
Drugs
Nitin Jain: The U.S. FDA approves lisocabtagene maraleucel for adults with relapsed or refractory CLL or SLL
Nitin Jain, The Director of the Leukemia CAR-T Program at the MD Anderson Cancer Center,…
Dec 5, 2023, 12:57 |
Drugs
Toby Eyre: Big news in CLL
Toby Eyre, CLL specialist at Oxford University Hospitals, announced on X/Twitter: "Big news in CLL.…
1
2
All:
12
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube